Variant report
Variant | rs6515304 |
---|---|
Chromosome Location | chr20:23118199-23118200 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:23109000-23120200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr20:23110400-23121600 | Weak transcription | Primary hematopoietic stem cells | blood |
3 | chr20:23111000-23120400 | Weak transcription | Pancreas | Pancrea |
4 | chr20:23112600-23120600 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr20:23114200-23120200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr20:23114200-23121800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr20:23114600-23119200 | Weak transcription | Spleen | Spleen |
8 | chr20:23114600-23120400 | Weak transcription | Fetal Lung | lung |
9 | chr20:23114600-23121800 | Weak transcription | Right Ventricle | heart |
10 | chr20:23114600-23122800 | Weak transcription | Right Atrium | heart |
11 | chr20:23115800-23122600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
12 | chr20:23116200-23118400 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr20:23116200-23119600 | Enhancers | Dnd41 | blood |
14 | chr20:23116400-23119600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
15 | chr20:23116400-23120000 | Enhancers | Esophagus | oesophagus |
16 | chr20:23116400-23120600 | Enhancers | Psoas Muscle | Psoas |
17 | chr20:23116600-23118400 | Enhancers | Fetal Muscle Trunk | muscle |
18 | chr20:23116600-23119200 | Enhancers | Fetal Muscle Leg | muscle |
19 | chr20:23116800-23118800 | Enhancers | Placenta | Placenta |
20 | chr20:23116800-23118800 | Enhancers | Placenta Amnion | Placenta Amnion |
21 | chr20:23116800-23119000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
22 | chr20:23116800-23119400 | Enhancers | HSMM | muscle |
23 | chr20:23116800-23120600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
24 | chr20:23116800-23120600 | Enhancers | NHEK | skin |
25 | chr20:23117000-23118200 | Enhancers | Hela-S3 | cervix |
26 | chr20:23117000-23119000 | Weak transcription | Fetal Thymus | thymus |
27 | chr20:23117000-23120000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
28 | chr20:23117000-23121600 | Weak transcription | Adipose Nuclei | Adipose |
29 | chr20:23117000-23121800 | Weak transcription | NHDF-Ad | bronchial |
30 | chr20:23117200-23120200 | Weak transcription | HUVEC | blood vessel |
31 | chr20:23117600-23118200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
32 | chr20:23117600-23118200 | Enhancers | Left Ventricle | heart |
33 | chr20:23117600-23118200 | Enhancers | Lung | lung |
34 | chr20:23117600-23118400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
35 | chr20:23117800-23118200 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |
36 | chr20:23117800-23118200 | Flanking Active TSS | K562 | blood |
37 | chr20:23117800-23122200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
38 | chr20:23117800-23122800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
39 | chr20:23118000-23118400 | Enhancers | HSMMtube | muscle |
40 | chr20:23118000-23119600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
41 | chr20:23118000-23122000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |